DONATE

Contact

Administration department Parc Científic de Barcelona (PCB) Edifici Clúster c/ Baldiri Reixac 10-12 08028 Barcelona Tel. +34 934 039 706 | info@ibecbarcelona.eu Laboratories Parc Científic de Barcelona (PCB): Edifici Hèlix … Read more

Welcome

It is beyond all doubt that a society can only face the future and improve quality of life by generating new knowledge to develop new solutions or technological improvements to … Read more

IBEC group uncovers new mechanism for wound healing

When we think of wound healing, we normally think of wounds to our skin. But wounds happen inside the body in all sorts of tissues and organs, and can have implications in many chronic diseases such as diabetes and asthma. Wounds also favour cancer progression by providing a physical and chemical environment that promotes the invasion of malignant cells.

Now, a group at the Institute for Bioengineering of Catalonia (IBEC) has found a new way to decipher the mechanisms of wound healing, and by doing so has uncovered a new understanding of how cells move and work together to close a gap in a tissue.

Delving deeper into the inner workings of cells

Research carried out at IBEC has opened the way to new applications to control the activation of neurons and other working parts of cells.

The dream of precisely and remotely controlling every aspect of the cell’s inner workings in tissue offers the promise of uncovering the molecular mechanisms of complex cellular processes, which in turn can lead to leaps in our understanding of what happens when things go wrong – for example, how and when neurodegenerative diseases can develop.

IBEC research on the cover of Nanotechnology

The latest article published by IBEC’s Nanoscale bioelectrical characterization group has made the cover of the journal Nanotechnology.

The paper, “Finite-size effects and analytical modeling of electrostatic force microscopy applied to dielectric films”, presents a model for the accurate quantification of EFM measurements on dielectric films on metallic substrates.

Heparin exhibits dual activity against malaria

A study by researchers from IBEC, ISGlobal and the University of Barcelona published in Nanomedicine opens the door to improved treatment of malaria with heparin.

Heparin (left) has been shown to have antimalarial activity and specific binding affinity for red blood cells infected with Plasmodium falciparum, versus non-infected blood cells. The study explores whether these properties could be exploited in a strategy based on the targeted delivery of antimalarial agents.